Creation of a platform dedicated to oncolytic viruses

Creation of a platform dedicated to oncolytic viruses

We are pleased to announce the creation of a platform dedicated to oncolytic viruses, to accelerate the time-to-market for your oncolytic viruses, from design to pre-clinical development! Don’t hesitate to contact us for more information!
contact@neovirtech.com

virus oncology oncolytic

oncolytic plateform

Recommended Posts

NeoVirTech and VirexpR have joined forces to develop an experimental test bench model of airborne contamination by poxviruses
NeoVirtech prélèvement
NeoVirTech will be present at the Eurosatory meeting
March 2024, NeoVirTech obtains funding from the AAP France 2030 to develop innovative theranostic platform for cancer virotherapies
NeoVirTech SAS and VirexpR SAS create a strategical alliance to combine NeoVirTech’s autofluorescent viruses with VirexpR nebulization technologies for airborne disinfection testing.